Tabula Rasa HealthCare, Inc. (TRHC) is devoted to leveraging technology to improve healthcare. TRHC has assembled an experienced and accomplished leadership team, who, along with our board of directors, have developed a proprietary solution set of technology-enabled products and services for medication management and risk adjustment.
TRHC decreases medication-related risk, reduces adverse drug events, enhances compliance and quality of care, and improves medication outcomes. CEO Dr. Calvin Knowlton offers some TRHC background and insight in a 2015 interview after winning the Remington Honor Medal. In this clip, Dr. Knowlton is introduced by American Pharmacists Association President Matt Osterhaus and interviewed by Mark L Walberg.
Dr. Knowlton has won numerous awards for his leadership in pharmacy, business, and philanthropy in his career of over 30 years, including the 2003 and the 2013 Ernest and Young Entrepreneur of the Year Award, Greater Philadelphia Region, and the 2004 Walter M. Aikman Entrepreneur of the Year Award. He was selected as the Most Influential U.S. Pharmacist in 1997. He has been elected and served as the national President for the American College of Apothecaries, President of the American Pharmacists Association (APhA) for two terms, and President of the American Pharmacists Association Foundation. He currently serves as Chair of the Board for the Evergreens Continuing Care Retirement Community and as a Board member on the Cooper Medical School of Rowan University. He serves on the Board (Session) of the First Presbyterian Church in Moorestown NJ and chairs their Long Range Planning Panel. He recently finished his term on the Boards of St Christopher’s Hospital for Children in Philadelphia, the Coriell Institute for Medical Research, and Coriell Life Sciences. He is a member of the APhA Pharmacogenomics Task Force, as well as the FDA-recognized National Pharmacogenomics Advisory Group.
Knowlton is the Founder and CEO of Tabula Rasa Healthcare, including CareKinesis, the first national PACE Medication Risk Mitigation Company. CareKinesis is the tenth company he has founded. excelleRx/Hospice Pharmacia was his most recent company prior to CareKinesis. In the aggregate, his companies have employed more than 1,300 people—mostly pharmacists, technicians and administrative staff. Launched in 2010, CareKinesis has already been showcased by the:
Recipient, Corporate Culture Awards, SmartCEO, 2016
Finalist, Circle of Excellence Awards, SmartCEO, 2016
Recipient, Enterprise Awards, Technology CEO of the Year, Phila Alliance for Capital & Technologies, 2016
Philadelphia Business Journal, Tech Disruptor Award, 2016
Recipient, Remington Honor Medal, Pharmacy’s Highest Award, 2015
Philadelphia Business Journal, Healthcare Individual Innovator Award, 2015
Enterprise Award Winner, Healthcare Innovator, Phila Alliance for Capital & Technologies
SmartCEO Voltage Award, Technology Innovator, Large Company, 2014
E & Y Entrepreneur of the Year, Healthcare Sector, Greater Philadelphia Region, 2013
Garden State Entrepreneur Excellence Award, for 2013
Philadelphia Business Journal, Best Places to Work 2012
NJ Technology Council, 2012 Growth Company of the Year
IMPACT2012, Featured Company
NJ Economic Development Authority, job-growth funding recipient for 2012 & 2013
Greater Philadelphia Alliance for Capital and Technologies, 2011 Enterprise Awards, Life Science Start-up Company of the Year
Knowlton received his pharmacy degree from Temple University, his Divinity degree from Princeton Theological Seminary, and his PhD in pharmacoeconomics from the University of Maryland. He served as Professor and Department Chair for the University of the Sciences in Philadelphia in the 1990s. He has authored and co-authored text books, book chapters, and articles focused on the role and responsibility of pharmacists in the outcomes of patient-centered medication care.